MAY 5, 2021 – PROVIDENCE, RI – RI Bio, the trade organization and voice of the Rhode Island Life Sciences industry, has formally launched a 501(c)3 Foundation arm to further support their mission.
“Our nonprofit foundation will concentrate on fundraising and enabling tax deductible contributions, an important incentive to attract corporate, foundation and individual charitable contributions, said Carol Malysz, RI Bio Executive Director. “Through the RI Bio Foundation, philanthropists can invest in programming and innovation that can change the world and transform lives as we grow the life sciences ecosystem to improve patient health, protect our climate, and nourish humanity.”
The foundation’s goal is three-fold – to deepen RI Bio’s impact on the industry as well as on patients; to increase investment in the people and companies who drive life sciences; and to create sustainable, stable income to support RI Bio’s mission.
Working together, RI Bio and the RI Bio Foundation seek to create an equitable world where the life sciences are accessible to all, where science and innovation can flourish, and where people and companies feel empowered to improve our health, protect our climate, and nourish humanity. RI Bio advances the industry through education, collaboration and advocacy. They share information and resources, provide access to capital, and create industry connections.
About RI Bio
As the trade group and voice of southeastern New England’s life sciences industry, RI Bio fosters strategic partnerships that can create a healthier world and grow the life sciences economy. They serve as a catalyst for biotech industry acceleration, advocating for better policy, educating a strong life science workforce, collaborating with life sciences companies, hospitals, universities, capital sources and government agencies, sharing information and expertise, and promoting the advancement of science. The result is improved quality of life, advanced innovation and discovery, and a robust life sciences ecosystem.